Asia Pacific Custom Antibody Market

Market Introduction

Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing a wide range of antibodies according to the researcher's requirements. There are various customized antibodies in the market, including polyclonal and monoclonal antibodies, recombinant monoclonal antibodies, hybridoma antibodies, polyclonal recombinant antibodies, etc. In addition, companies offer complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titre analysis, and final antibody purification.

Thus, the high demand in research is expected to create a significant demand for custom antibody in the coming years, which is further anticipated to drive the custom antibody market.

Countries in the Asia Pacific are encountering challenges due to rising incidences of COVID-19. The COVID-19 pandemic has put a significant strain on the health systems of many countries around the world. Testing capacity in many Asia Pacific nations was limited and of low quality in the initial days of the pandemic, which led to a surge in the COVID-19 cases. However, many countries, such as South Korea, Japan, and Singapore, were efficiently contained the situation through robust tracking and testing. Also, India has the second-highest number of cases in the world after the US. Thus, COVID-19 has created an extraordinary emergency that is particularly affecting the supply chain. The supply chain disruptions, along with the enormous demand for effective diagnostics and therapeutics for the treatment of COVID 19, have put the healthcare research industry in a critical situation in the Asia Pacific region. However, many market players now realized the importance of antibody testing for COVID 19, which is expected to raise demand for custom antibodies during the forecast period.

Asia Pacific Custom Antibody Strategic Insights

Strategic insights for the Asia Pacific Custom Antibody provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Custom Antibody Report Scope

Asia Pacific Custom Antibody Regional Insights

The geographic scope of the Asia Pacific Custom Antibody refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Custom antibody market in Asia Pacific is expected to grow from US$ 82.3 million in 2021 to US$ 174.8 million by 2028; it is estimated to grow at a CAGR of 11.4% from 2021 to 2028. Antibodies, including monoclonal and polyclonal, find applications in academic, research, and pharmaceutical institutes and organizations. Using these antibodies, institutes and organizations conduct several research and development activities for drug and biomarker developments, and other therapeutic and clinical diagnostics product developments.  Custom antibodies are widely preferred in research to differentiate the antibody products. These antibodies are continuously evaluated to provide safe, accurate, and efficient products with improved quality. For instance, in January 2020, as per World Health Organization (WHO), collaborative team of Chinese and Australian researchers have published their research for first genome of the virus. The SARS-CoV-2 was critical for research studies, especially in the studies pertaining to development of vaccines against it. Thus, the virus was sequenced over 3,000 times till May 13, 2020, to make its genetic map freely available to researchers globally, which generated huge demand for custom antibodies. Small and medium-sized companies have increased their research and development investments and activities exponentially. Such investments have escalated the demand for custom antibodies.

Key Market Segments

In terms of service, the antibody development segment accounted for the largest share of the Asia Pacific custom antibody market in 2020. In terms of type, the monoclonal antibodies segment accounted for the largest share of the Asia Pacific custom antibody market in 2020. In terms of source, the mice segment accounted for the largest share of the Asia Pacific custom antibody market in 2020. In terms of research area, the oncology segment held a larger market share of the custom antibody market in 2020. In terms of end user, the pharmaceutical and biotechnology companies segment held a larger market share of the custom antibody market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the custom antibody market in Asia Pacific are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck KGAA, Abcam, Genscript, Agilent Technologies, Inc., and Cell Signaling Technology, Inc.

Reasons to buy report

• To understand the Asia Pacific custom antibody market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia Pacific custom antibody market
• Efficiently plan M&A and partnership deals in Asia Pacific Custom antibody market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Asia Pacific Custom antibody market
• Obtain market revenue forecast for market by various segments from 2021-2028 in Asia Pacific region.

ASIA PACIFIC CUSTOM ANTIBODY MARKET SEGMENTATION

By Service

• Antibody Development
• Antibody Production and Purification
• Antibody Fragmentation and Labelling

By Type

• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Custom Antibodies

By Source

• Mice
• Rabbits
• Others

By Research Area

• Oncology
• Immunology
• Stem Cells
• Infectious Diseases
• Neurobiology
• Cardiovascular Diseases
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organizations

By Country

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Mentioned

1. Thermo Fisher Scientific Inc.
2. Bio-Rad Laboratories Inc.
3. Merck KGAA
4. Abcam
5. Genscript
6. Agilent Technologies, Inc.
7. Cell Signaling Technology, Inc.